Now showing items 1-1 of 1
Development of a Novel Strategy for Targeted Delivery of siRNA to B lymphocytes
(Queen Mary University of London, 25/03/2014)
This study describes “proof of concept” experiments for development of a novel therapy to target B cells in pathological settings such as cancer and inflammation. Targeted biological therapies including monoclonal antibodies ...